XML 345 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated statement of cash flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities (including discontinued operations)      
Profit before taxes from continuing operations $ 552 $ 175 $ 238
Profit before taxes from discontinued operations (3) 4 116
Profit before taxes 549 179 354
Adjustments to reconcile to net cash:      
Interest expense on leases 122 117 131
Interest expense on debt and other financing 594 595 497
Interest and other financial income (46) (28) (18)
Adjustments for non-cash items:      
Depreciation and amortization 1,234 1,338 1,364
Share of profit in joint ventures (54) (42) (32)
Gain on disposal and impairment of assets, net (54) (10) (122)
Share-based compensation 50 52 29
Loss from other associates and joint ventures, net 0 3 0
Other non-operating (income) expenses, net 119 (36) 77
Changes in working capital:      
Decrease (increase) in trade receivables, prepayments and other current assets, net 36 (245) (104)
Decrease (increase) in inventories 0 11 5
Increase (decrease) in trade and other payables, net (92) 47 (37)
Changes in contract assets, liabilities and costs, net (42) 65 (14)
Total changes in working capital (97) (123) (151)
Interest paid on leases (120) (115) (128)
Interest paid on debt and other financing (499) (505) (411)
Interest received 43 31 8
Taxes paid (239) (233) (316)
Net cash provided by operating activities 1,603 1,223 1,284
Cash flows from investing activities (including discontinued operations):      
Acquisition of subsidiaries, joint ventures and associates, net of cash acquired 0 0 (283)
Proceeds from the disposal of subsidiaries and associates 5 0 152
Purchase of spectrum and licenses (135) (236) (93)
Purchase of other intangible assets (94) (133) (179)
Purchase of property, plant and equipment (540) (814) (800)
Proceeds from sale of property, plant and equipment 58 17 21
Dividends and dividend advances received from joint ventures and associates 66 63 10
Settlement of derivative financial instruments 9 (26) 11
Transfer (to) / from pledge deposits, net 5 (6) 33
Loans granted within the Tigo Money lending activity, net (2) (4) (3)
Cash (used in) provided by other investing activities, net 25 24 25
Net cash used in investing activities (604) (1,116) (1,104)
Cash flows from financing activities (including discontinued operations):      
Proceeds from debt and other financing 604 362 1,570
Repayment of debt and other financing (1,366) (632) (2,127)
Lease capital repayment (204) (177) (157)
Capital injection in subsidiary (Non-controlling interests' portion) 0 74 0
Proceeds from the rights offering, net of costs 0 0 717
Advances and dividends paid to non-controlling interests 0 0 (4)
Share repurchase program (99) (5) 0
Net cash from (used in) financing activities (1,066) (377) (1)
Exchange impact on cash and cash equivalents, net (8) 6 (11)
Net increase (decrease) in cash and cash equivalents (76) (264) 168
Cash and cash equivalents, beginning balance 775 1,039 895
Effect of cash in disposal group held for sale 0 0 (24)
Cash and cash equivalents, ending balance $ 699 $ 775 $ 1,039